Get addiction help now: (858) 363-8214

get help now

Get addiction help now: (858) 363-8214

get help now

CERTIFIED METHADONE ADVOCATE (CMA)-1

Time to read: 2 min

The Advocacy Training Session

The training for certification includes a
variety of topics to give advocates a well-grounded understanding of
methadone treatment, research, regulations and laws that protect
methadone patients and programs.

  1. Addiction and Methadone The
    biological constructs of addiction will be explained in a way that
    can be understood by lay people (i.e. opiate receptors, Endorphins)
    Methadone dose and what is considered an adequate dose and why it is
    important and what methadone does to make you feel normal.
  2. Regulations and Accreditation The new federal regulations will be explained:  What
    they are and how they relate to the state regulations? Accreditation
    and what an accreditation survey is, how it is done, and how
    advocates can be involved.
  3. The Different Faces of Advocacy Advocates from around the country will explain what they do to
    advance the goals of methadone advocacy. This session will also
    explain the different types of advocacy that advocates are involved
    in.
  4. How to End Methadone Stigma The history of
    methadone stigma will be presented and how it has impacted methadone
    treatment and the recipients of it. A plan for advocates to work on
    for ending it will be revealed.
  5. Advocate Certification What is certification and how it
    will professionalize those committed to methadone advocacy.  The Advocates Code of Ethics, the Goals of Methadone
    Advocacy, and Advocate Certification.

Similar Posts

  • Ways to Help NAMA Recovery

    ByAdmin
    Admin 05/16/2023

    How can I help NAMA-R? Here’s how. Join NAMA-R Sounds simple really especially when patients, family, professionals, policy makers, state methadone authorities, students and so on depend on NAMA for information and help. But for some reason many think that others will do it or they forget. NAMA depends on membership dues to pay for…

  • Page 4098 Federal Register

    ByAdmin
    Admin 08/28/2021

     Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i)                 Unsupervised or take-home use.   To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements.   (1)   Any patient…

  • Figure 3 The Methadone Molecule

    ByAdmin
    Admin 05/15/2023

       Contents          The Pharmacology of Opioids  Cont.      Back    Education Series Number 5.1  February 2001 (Revised)  Part 2 continued     Figure 3 The Methadone Molecule.  The two dimensional representation of the methadone molecule is very different from that of morphine. However, molecules are three dimensional and the methadone molecule bends into a structure that is very…

  • NAMA Organizational Meeting Monday, October 8th, 7 P.M.

    ByAdmin
    Admin 09/24/2022

    NAMA Organizational Meeting Monday, October 8th, 7 P.M. Chairs Jo Sotheran, NAMA Board of Directors (Treasurer) Joycelyn Woods, NAMA Board of Directors (President) As meeting starts Joycelyn Woods looks on over the shoulders of Tony Scro (NAMA Grievance Coordinator), James DePasquale (Long Island NAMA) and Donna Schoen (LIJ Patient Committee). Jo Sotheran introduces the reasons…

  • NAMA Needs Volunteers!

    ByAdmin
    Admin 02/05/2022

    Contact the Executive Director NAMA Recovery needs help with two major things: 1. Website, 2. Funding. Programmers to help with the website. Funding Membership Drives or just asking your program if you can hang up some NAMA Recovery flyers that can bring in new members and of course spread the word about what we do….

  • National Alliance for Medication Assisted Recovery

    ByAdmin
    Admin 09/27/2021

    National Alliance for Medication Assisted Recovery CONFIDENTIAL Grievance/Compliment Report All information that is provided will be held strictly confidential in the same manner as the patient protections described in the U.S. Federal Confidentiality Regulations 42 CFR and the Standards for Privacy of Individually Identifiable Health Information (the Privacy Rule) as established by the Department of…